CornerLoc™ today announced the publication of 6-month interim results from the SPARTAN Study, a prospective, multicenter clinical study designed to assess patient-reported pain and functional outcomes ...
The latest update on Newell Brands trims the fair value estimate slightly, from US$5.18 to US$5.05 per share, while keeping the discount rate steady at 12.5%. Long term revenue growth assumptions have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback